Many syntheticcannabinoids were designed by Pfizer in the 1970s and 1980s, and feature an alphanumeric code beginning with the prefix "CP" (afterCharles Pfizer).[1] Recently, several members of this class of cannabinoids have been discovered in recreational drug products.[2][3][4]